Indices in this article
NEW YORK (dpa-AFX) – The initial momentum recorded on Monday on the New York stock market has subsided. Still at a record high in early trading, the Dow Jones Industrial (Dow Jones 30 Industrial) traded a good two and a half hours before the close of the market, only plus 0.09 percent to 34,966.18 points. The papers of the Bank Goldman Sachs were in the lead index with plus 1.4 percent. For the broad-market S&P 500 index, it recently rose 0.13 percent to 4401.19 points.
The technology-heavy selection index NASDAQ 100 gained 0.37 percent to 15 014.82 points. Nevertheless, Amazon hardly made any progress with a plus of 0.1 percent. A recovery after its high loss on Friday, when the online retailer issued a surprisingly cautious forecast for the current quarter, did not materialize.
The mood in US industry had surprisingly clouded over in July. This did not affect the courses. However, market observers rated the deliberations of the US Senate on a new trillion dollar infrastructure program, which are apparently nearing completion, as positive.
The shares of Biontech (BioNTech (ADRs)) listed in New York rose by 3.8 percent and cost almost $ 354 at their peak, continuing their record rally. They benefited from the prospect of booster vaccinations against the corona virus, the increased use also in children and adolescents, and the prospect that mRNA technology could also become marketable for other areas of application. Against this background, the private bank Berenberg rushed ahead on Monday and raised its price target significantly to $ 400.
Square titles went up nearly twelve percent. With the takeover of the Australian payment service provider Afterpay, the US payment service wants to expand its business with installment payments. The deal, valued at a good 29 billion US dollars, should be completed in the first quarter of next year, both companies announced./ajx/he
–